164 related articles for article (PubMed ID: 23696192)
1. Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis.
Shiozawa Y; McGee S; Pienta MJ; McGregor N; Jung Y; Yumoto K; Wang J; Berry JE; Pienta KJ; Taichman RS
J Cell Biochem; 2013 Nov; 114(11):2471-8. PubMed ID: 23696192
[TBL] [Abstract][Full Text] [Related]
2. BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis.
Seo SI; Gera L; Zhau HE; Qian WP; Iqbal S; Johnson NA; Zhang S; Zayzafoon M; Stewart J; Wang R; Chung LW; Wu D
Clin Cancer Res; 2008 Oct; 14(19):6198-206. PubMed ID: 18829499
[TBL] [Abstract][Full Text] [Related]
3. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.
Shigemura K; Arbiser JL; Sun SY; Zayzafoon M; Johnstone PA; Fujisawa M; Gotoh A; Weksler B; Zhau HE; Chung LW
Cancer; 2007 Apr; 109(7):1279-89. PubMed ID: 17326044
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy.
Todaro M; Turdo A; Bartucci M; Iovino F; Dattilo R; Biffoni M; Stassi G; Federici G; De Maria R; Zeuner A
Cancer Res; 2013 Nov; 73(21):6393-400. PubMed ID: 24008319
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
6. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
7. Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.
Liang W; Wang F; Chen Q; Dai J; Escara-Wilke J; Keller ET; Zimmermann J; Hong N; Lu Y; Zhang J
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1999-2012. PubMed ID: 31172267
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models.
Hedley BD; Chu JE; Ormond DG; Beausoleil MS; Boasie A; Allan AL; Xenocostas A
Clin Cancer Res; 2011 Oct; 17(19):6151-62. PubMed ID: 21856770
[TBL] [Abstract][Full Text] [Related]
9. Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth.
Cunningham D; Parajuli KR; Zhang C; Wang G; Mei J; Zhang Q; Liu S; You Z
Prostate; 2016 Nov; 76(15):1420-30. PubMed ID: 27325602
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer.
Banerjee S; Hussain M; Wang Z; Saliganan A; Che M; Bonfil D; Cher M; Sarkar FH
Cancer Res; 2007 Apr; 67(8):3818-26. PubMed ID: 17440096
[TBL] [Abstract][Full Text] [Related]
13. SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.
Rabbani SA; Valentino ML; Arakelian A; Ali S; Boschelli F
Mol Cancer Ther; 2010 May; 9(5):1147-57. PubMed ID: 20423991
[TBL] [Abstract][Full Text] [Related]
14. The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.
Elshafae SM; Kohart NA; Altstadt LA; Dirksen WP; Rosol TJ
Prostate; 2017 May; 77(7):776-793. PubMed ID: 28181686
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils are mediators of metastatic prostate cancer progression in bone.
Costanzo-Garvey DL; Keeley T; Case AJ; Watson GF; Alsamraae M; Yu Y; Su K; Heim CE; Kielian T; Morrissey C; Frieling JS; Cook LM
Cancer Immunol Immunother; 2020 Jun; 69(6):1113-1130. PubMed ID: 32114681
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
17. Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.
Angelucci A; Gravina GL; Rucci N; Millimaggi D; Festuccia C; Muzi P; Teti A; Vicentini C; Bologna M
Endocr Relat Cancer; 2006 Mar; 13(1):197-210. PubMed ID: 16601288
[TBL] [Abstract][Full Text] [Related]
18. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of anemia and bone metastasis in metastatic non-small-cell lung cancer. A French survey].
Brechot JM; Roche N; Marichy C; Lebeau B; Debieuvre D; Darneau G; Coste E; Grivaux M; Falchero L; Vlastos F; Souquet PJ;
Rev Pneumol Clin; 2005 Feb; 61(1 Pt 1):23-9. PubMed ID: 15772576
[TBL] [Abstract][Full Text] [Related]
20. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
